NIH Tries a New Approach to Speed Drug Development
Date: February 19, 2014
The Washington Post published an Editorial earlier this month highlighting the National Institutes of Health (NIH)’s new project that hopes to modify the industry’s current model of drug development. Traditionally, pharmaceutical companies are isolated in their development research to potentially discover a “blockbuster drug” that would result in major profits. NIH’s new project, however, is heavily focused on teamwork and collaboration with respect to drug development. Concentrating on four major diseases (Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus), the “Accelerating Medicines Partnership” project has already brought together 10 drug companies, the federal government and several nonprofit organizations and research foundations to collaborate on researching new drug therapies. Read the entire article on the Washington Postwebsite.